Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Landmark Meeting Will Explore Inflammation as a Key Risk Factor in Stroke and Opportunities for Therapeutic Intervention

Interdisciplinary researchers will convene May 9 & 10 at the New York Academy of Sciences.

Published May 05, 2010

The New York Academy of Sciences presents a landmark international symposium to explore innate inflammation as a key element in cerebrovascular disease on May 9 and 10, 2010. Recent discoveries have unveiled innate inflammation as an important risk factor leading to stroke and transient ischemic attacks, and have also opened new avenues for prevention and therapeutic intervention in cerebrovascular disease.

Discussions at this one-and-a-half-day event, “Innate Inflammation as the Common Pathway of Risk Factors Leading to Transient Ischemic Attacks and Stroke: Pathophysiology and Potential Interventions,” will cover in vitro studies inflammatory response mechanisms; in vivo studies of inflammatory response in animal models; data from human samples; and clinical implications. These discussions, their dissemination through the Annals of the New York Academy of Sciences, and the collaborations emerging from this forum will ultimately advance translational research in this critical area and help build and strengthen ties among disciplines, fostering cross-disciplinary collaborations related to inflammation, vessel wall disease, and stroke.


Gregory J. del Zoppo, MD, University of Washington School of Medicine
Philip B. Gorelick, MD, MPH, FACP, University of Illinois College of Medicine at Chicago School of Medicine

Keynote Address
John Hallenbeck, MD, National Institute of Neurological Disorders and Stroke

And presentations by more than 25 experts in inflammatory disease, CNS disease, and stroke

WHAT: A symposium: Innate Inflammation as the Common Pathway of Risk Factors Leading to Transient Ischemic Attacks and Stroke: Pathophysiology and Potential Interventions

WHEN: Sunday, May 9, 2010 | 4:30 PM - 6:30 PM, followed by reception and dinner.
Monday, May 10, 2010 | 7:30 AM - 5:30 PM, followed by reception

WHERE: The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St., 40th floor

Register and see speaker biographies at Media must RSVP:
Adrienne Burke, (212) 298-8655 and

The New York Academy of Sciences is an independent, not-for-profit organization committed to advancing science, technology, and society worldwide since 1817. With 24,000 members in 140 countries, NYAS is creating a global community of science for the benefit of humanity. NYAS' core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large.